HIGHLIGHTS
- who: Ryoma Nakao from the (UNIVERSITY) have published the Article: A highly immunogenic vaccine platform against encapsulated pathogens using chimeric probiotic Escherichia coli membrane vesicles, in the Journal: (JOURNAL) of 30/05/2022
- what: Considering the difficulty of inducing robust and long-lasting immune_responses to polysaccharide antigens, this study assessed the applicability of glycine-induced MVs as a novel vaccine platform against infection by encapsulated pathogens.
- how: The thermostability of CPS14+MVs was examined (Fig 3H) and those results showed that the total protein profiles CPS14 expression/polymerization morphology of the heat-treated . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.